The identification of driver mutations in JAK2, CALR, and MPL genes, along with histological analysis of bone marrow biopsies and multi-disciplinary team meetings, should be standardized for all young patients with ET or PV. This evidence concerns the gene JAK2 and acquired polycythemia vera.